|
|
在研机构- |
|
在研适应症- |
|
最高研发阶段未知 |
首次获批国家/地区- |
首次获批日期- |
A Multicenter, Active Control, Parallel Group, Randomized, Double-blind, Phase II Clinical Trial to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops in Patients With Dry Eye Disease
This study is planned to Evaluate the Efficacy and Safety of SCAI-001 Eye Drops(Cyclosporine 0.01%, 0.02%) compared to Restasis(Cyclosporine 0.05%) in Patients with Dry Eye Disease.
100 项与 Sky Therapeutics Co. Ltd. 相关的临床结果
0 项与 Sky Therapeutics Co. Ltd. 相关的专利(医药)
100 项与 Sky Therapeutics Co. Ltd. 相关的药物交易
100 项与 Sky Therapeutics Co. Ltd. 相关的转化医学